Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3.
Dogan DY, Urzica EI, Hornung I, Kastl P, Oguama D, Fette FM, Nguyen LH, Rosenbauer F, Zacharowski K, Klingmüller U, Gradhand E, von Knethen A, Popp R, Fleming I, Schrader L, Steinbicker AU.
Dogan DY, et al. Among authors: urzica ei.
Blood Adv. 2024 Jun 11;8(11):2870-2879. doi: 10.1182/bloodadvances.2023012322.
Blood Adv. 2024.
PMID: 38588481
Free PMC article.